ARX 2.73% 53.5¢ aroa biosurgery limited

PNV financials are out. not a direct competitor but worth...

  1. 359 Posts.
    lightbulb Created with Sketch. 31
    PNV financials are out.
    not a direct competitor but worth reading.

    PNV has $6.1m cash balance as at 30 June 2022, INCLUDING the proceeds from its property (sold for $6.3m).

    its operating cash flow deteriorated from negative $250k to negative $2m in 2022.

    there is no significant increase in account receivables $6m (2021: $5.67m) so I don't see an immediate improvement in PNV's cash flow. it may need additional capital injection IMO.

    ARX has $55m cash at bank as at 30 June 2022.
 
watchlist Created with Sketch. Add ARX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.